Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 66.39 | 6.81 |
PEG Ratio (TTM) | 0.59 | -0.80 |
P/S Ratio (TTM) | 3.06 | 0.73 |
P/B Ratio (TTM) | 0.48 | 1.12 |
P/FCF Ratio (TTM) | 122.02 | 13.08 |
Price to 5YR AVG Earnings Ratio | 3.74 | 6.67 |
Price to 5YR AVG FCF Ratio | 39.71 | 7.13 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.36% | 5.39% |
ROE (TTM) | 0.69% | 8.38% |
Net Profit Margin (TTM) | 0.46% | 5.43% |
ROIC 5YR AVG | 23.34% | 18.88% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -13.55% | 121.39% | 49.77% |
Revenue | -3.86% | 19.63% | 13.64% |
Net Income | -12.97% | 122.26% | 50.25% |
Cash Flow | -14.62% | 17.88% | 9.46% |
Health (77%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.91 | 2.42 |
Quick Ratio (TTM) | 1.67 | 1.39 |
D/E Ratio (TTM) | 0.18 | 0.33 |
Interest Coverage (TTM) | 8.60 | 31.55 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 5.77 | 3.30 |
LTL to 5YR AVG FCF | 0.97 | 2.88 |
Shares Outstanding Growth 5YR AVG | N/A | -3.66% |